Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jerome, Bejaud"'
Autor:
Milad Baroud, Elise Lepeltier, Yolla El-Makhour, Nolwenn Lautram, Jerome Bejaud, Sylvain Thepot, Olivier Duval
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1317 (2021)
5-Azacitidine, a cytidine analogue used as a hypomethylating agent, is one of the main drugs for the treatment of myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) in the elderly. However, after administration, it exhibits several lim
Externí odkaz:
https://doaj.org/article/b21738572f654089beb9c95d5a35e179
Autor:
Duval, Milad Baroud, Elise Lepeltier, Yolla El-Makhour, Nolwenn Lautram, Jerome Bejaud, Sylvain Thepot, Olivier
Publikováno v:
Pharmaceuticals; Volume 14; Issue 12; Pages: 1317
5-Azacitidine, a cytidine analogue used as a hypomethylating agent, is one of the main drugs for the treatment of myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML) in the elderly. However, after administration, it exhibits several lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::43bcfa12dd10449c477143d1fe9e96ad
Autor:
Thomas, Briot, Emilie, Roger, Naila, Bou Haidar, Jerome, Bejaud, Nolwenn, Lautram, Catherine, Guillet, Sylvain, Thépot, Samuel, Legeay, Frederic, Lagarce
Publikováno v:
International Journal of Nanomedicine
Background Acute myeloid leukemia mainly affects adult patients. Complete remission for patients younger than 60 years, who are candidates for standard induction therapy, is achieved in 60%–80% of cases. However, the prognosis is still poor for old
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::848c38eb198a751ac0536550a029705b
https://pubmed.ncbi.nlm.nih.gov/30988610
https://pubmed.ncbi.nlm.nih.gov/30988610